Stay updated on Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer metadata and indexing terms were expanded to include IPD sharing, FDA-regulated status, and additional related terms for indexing and search. No core study content or eligibility criteria were altered.
    Difference
    100%
    Check dated 2026-05-29T23:09:09.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Core sections including the Study Overview, locations and contacts, and study status were removed, leaving less information about the EV-103 urothelial cancer trial.
    Difference
    20%
    Check dated 2026-05-22T14:46:14.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a version update to the study record page rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-05-15T11:45:24.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:17.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:38.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study EV-103 (NCT03288545) was terminated by the sponsor after meeting enrollment targets and primary objectives, with data collected for planned regulatory filings. The page updates recruitment status to reflect termination, including removal of the 'Active, not recruiting' designation and related dates.
    Difference
    0.2%
    Check dated 2026-03-26T04:01:41.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.